• About Us
  • The Team
    • David Docherty
    • Richard Greenhalgh
  • Associates
    • Dr Cathy Garner
    • Madeleine King
    • Peter Forbes, Associate Director, CIHE
    • Philip Ternouth, Associate Director, CIHE
  • Council Members
    • Alan Jenkins, Managing Director, Kaplan Open Learning
    • Alberto de Benedictis, Chief Executive, Finmeccanica UK
    • Andrew McNaughton, Deputy Chief Executive, Balfour Beatty Plc
    • Antonio Simoes, Deputy Chief Executive, HSBC Bank PLC
    • Arnold Longboy, Managing Director, Executive Education and External Relations, EMEA, University of Chicago Booth School of Business
    • Christopher Saul, Slaughter and May
    • David Abraham, Channel 4
    • David Eyton, BP
    • Dominic Casserley, McKinsey & Company
    • Dr David Grant, Vice-Chancellor, Cardiff University
    • Eric Thomas, University of Bristol
    • Gavin Patterson, BT Retail
    • Geoff Mulgan, Chief Executive, NESTA
    • Harvey McGrath, Prudential plc
    • Iain Gray, Chief Executive, Technology Strategy Board
    • Ian Sarson, Compass Group
    • Jeremy Darroch, Sky
    • Joe Greenwell CBE, Chairman, Ford of Britain
    • John Stewart, Legal & General
    • John Widdowson CBE, New College Durham
    • Kevin Sneader, Director and Managing Partner, McKinsey & Company
    • Marianne Fallon, Partner, Executive Board Member, UK Head of Corporate Affairs, UK Head of Charities, KPMG LLP
    • Michael Stevenson, Cisco
    • Nick Winser, National Grid
    • Nicola Dandridge, Chief Executive, Universities UK
    • Oliver Benzecry, Managing Director – UK & Ireland, Accenture
    • Patrick Hynes, UK Managing Director, Spencer Stuart
    • Phil Smith, Cisco
    • Professor Andrew Hamilton, Vice-Chancellor, University of Oxford
    • Professor Anton Muscatelli, University of Glasgow
    • Professor Antony J Chapman, Vice Chancellor, Cardiff Metropolitan University
    • Professor Colin Riordan, Vice-Chancellor, Cardiff University
    • Professor Dame Julia King, Aston University
    • Professor Don Nutbeam PhD FFPH, Vice Chancellor, University of Southampton
    • Professor Geneviève Berger, Chief Research & Development Officer, Unilever
    • Professor Graham Henderson, Teesside University
    • Professor Ian Diamond FBA FRSE AcSS, Vice-Chancellor, University of Aberdeen
    • Professor Julian M Crampton, University of Brighton
    • Professor Keith Burnett CBE, FRS, Vice-Chancellor, The University of Sheffield
    • Professor Madeleine Atkins, CBE, Vice-Chancellor, Coventry University
    • Professor Malcolm Grant, University College London
    • Professor Mark Smith, Vice-Chancellor, Lancaster University
    • Professor Michael Arthur, Vice-Chancellor, University of Leeds
    • Professor Pat Loughrey, Goldsmiths
    • Professor Patrick Vallance, President, Pharmaceuticals R&D, GSK
    • Professor Peter Downes, University of Dundee
    • Professor Quintin McKellar CBE, University of Hertfordshire
    • Professor Robert Allison, University of Loughborough
    • Professor Sir Adrian Smith, FRS, Vice-Chancellor, University of London
    • Professor Sir Christopher Snowden, University of Surrey
    • Rona Fairhead, Financial Times Group
    • Sam Laidlaw, Centrica Plc
    • Simon Bradley, EADS
    • Simon Lowth, AstraZeneca
    • Sir Alan Langlands, Chief Executive, HEFCE
    • Sir John Parker, Anglo American
    • Sir Martin Sorrell, Chief Executive, WPP
    • Sir Philip Hampton, RBS Group
    • Sir Rodney Brooke CBE, Chairman, QAA
    • Sir Roger Bone, President, Boeing UK Ltd
    • Steve Pateman, Executive Director, Head of UK Banking, Santander UK plc
    • Tim Melville-Ross CBE, HEFCE
    • Tracy Clarke, Standard Chartered Bank
    • Wendy Purcell, University of Plymouth
    • William Archer, Chief Executive Officer, i-graduate
    • William Macpherson, Chief Executive, QA
  • Funding Organisations
  • Trustees
    • Dr Martin Read, non-executive director of Invensys, Aegis Group, Lloyd’s
    • Professor Nigel Thrift, Vice-Chancellor, University of Warwick
    • Sir Richard Lambert
  • Affiliates
  • Contact Us
    • Search results

Professor Patrick Vallance, President, Pharmaceuticals R&D, GSK

Patrick was appointed President, Pharmaceuticals R&D, in January 2012. Prior to his appointment he was Senior Vice President, Medicines Discovery and Development. He is a member of the Corporate Executive Team. As president of R&D he is responsible for ensuring that GSK maintains a flow of potential new medicines through the R&D pipeline from early discovery through to approval.

Patrick joined the company in May 2006 as Head of Drug Discovery. He transformed GSK’s discovery engine to focus on therapy areas that are underpinned by the most promising and mature science, and set up small, empowered teams, called Discovery Performance Units, to drive success of potential new medicines in the pipeline. This new approach has led to a number of potential new medicines progressing into late-stage development.

Prior to joining GSK Patrick was a clinical academic and led the Division of Medicine at University College London.